2019 Clinical Lab Fraud & Abuse Update

$99.00

Description


2019 Clinical Lab Fraud & Abuse Update


Presenter: Danielle Sloane
Partner, Bass, Berry & Sims
 
When: Thursday, April 25, 1:00 p.m. ET (10 a.m. PT)
Duration: 60 minutes
Price: $99.00

The stakes associated with compliance with federal and state laws have never been higher. Clinical labs are continuing to find themselves the target of investigations, audits, lawsuits, and even criminal investigations by CMS, OIG, DOJ and other federal and state agencies.

Whistleblowers continue to file qui tam lawsuits under the False Claims Act. And, apart from that, the government continues to dedicate resources to investigate Anti-Kickback Statute and Stark Law violations, and payment fraud.

Now, that’s just the tip of the enforcement iceberg!

The new Eliminating Kickbacks in Recovery Act of 2018 (EKRA) now prohibits kickbacks related to
any laboratory service paid for by a federal healthcare program or commercial health insurer, and specifically prohibits paying for sales and marketing personnel based on commissions.

Protect Your Lab against Costly Fraud and Abuse Violations

Join us on April 25th to hear from Danielle Sloane, Partner at Bass, Berry & Sims and noted lab compliance expert, who will discuss recent fraud and abuse cases and settlements impacting the laboratory industry, explain what you can do to protect your lab against similar violations, and outline what you need to know about how EKRA affects your sales and marketing practices.

Here’s just a sample of what you’ll learn at this Webinar:

  • Analysis of recent fraud and abuse court cases and settlements and what they mean to your lab policies and practices.
  • Review of recent whistleblower cases and steps your lab can take to avoid problematic practices.
  • The scope of the new EKRA, including what laboratory services it covers and how it affects lab sales and marketing practices.
  • Review of recent and proposed changes to Stark, False Claims and Anti-Kickback laws, rules and regulations.
  • The most common compliance violations and how to avoid them, including
    case studies that demonstrate how other labs are dealing with current compliance and enforcement challenges.
  • Compliance program considerations and tips to enable your laboratory to capture and resolve compliance issues before they become big problems.
  • Current CMS enforcement programs and initiatives.
  • And much more!

Make no mistake: A laboratory’s compliance efforts are more important than ever to ensure the integrity of your laboratory revenue and avoid the debilitating costs of an enforcement action. This webinar shows what you can do NOW to protect your lab and comply with the new laws and regulations.

Your Presenter:

Danielle Sloane, Partner, Bass, Berry & Sims

As a Partner in the nationally recognized Healthcare Practice Group at Bass, Berry & Sims, Danielle Sloane helps national life science and healthcare clients navigate the complex maze of federal and state healthcare laws and regulations. With an analytical eye, Danielle helps her clients mitigate legal risk and achieve regulatory compliance consistent with their business goals. Working with clients ranging from hospitals and ambulatory surgical centers to medical device companies and laboratories, Danielle’s practice involves compliance, regulatory and operational matters, transactional structuring and diligence and government investigations.

Danielle advises clients on growth strategies by determining how they can best innovate, evolve and improve patient care within the confines of current healthcare regulatory laws. In addition, she works closely with corporate attorneys related to verifying transactions are in compliance with fraud and abuse laws, and conducting diligence on a prospective healthcare entity. She also provides valuable healthcare regulatory analysis as a team member of the firm’s healthcare investigations group.

Danielle currently serves on the Bloomberg Law Health Care Practice Innovation Board, and is a frequent speaker and writer on healthcare regulatory and compliance matters. Danielle was recognized by Law360 as a Rising Star in healthcare in 2017.


(-00000store)